The United States government recently announced changes to existing and future investment in messenger ribonucleic acid (mRNA) vaccine technology, which was discovered in the early 1960s.
On August 5, 2025, the U.S. Department of Health and Human Services (HHS) stated that a coordinated wind-down of its mRNA vaccine development activities under the U.S. Biomedical Advanced Research and Development Authority (BARDA) had begun, including the cancellation and de-scoping of various contracts and solicitations.
mRNA Vaccine Technology Downgraded
World-First Gonorrhoea Vaccination Program Launches in England
The United Kingdom (UK) has recently initiated a significant shift from a focus on treating illness to prioritizing prevention, as part of its Plan for Change aimed at making the NHS fit for the future.
In the UK, people are experiencing more years of ill health, and the disparity in healthy life expectancy between the wealthiest and the poorest is widening.
To better protect those at high risk of gonorrhoea, the NHS and local authorities have begun rolling out a world-first vaccination program in England.
Larazotide May Speed Recovery in Children With Multisystem Inflammatory Syndrome
Faster resolution of GI symptoms, faster clearance of spike antigen, faster return to usual activities reported for children treated with larazotide
COVID-19 mRNA Vaccine Targeting Omicron JN.1 Lineage Safe
No significant increases seen in rate of hospital contacts for any of 29 adverse events in 28-day risk period after vaccination